Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04388748 · ClinicalTrials.gov registry record · NA
Stress Management and Resiliency Training for Depression vs Treatment as Usual in the Treatment of Major Depression
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT04388748: Completed NA study, sponsored by Mayo Clinic.
NCT04388748 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04388748, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Researchers are trying to find out if a Stress Management and Resiliency Training (SMART-D) therapy will help with major depression treatment.
Primary Outcome
Measured using the patient health questionnaire (PHQ-9) where total scores are reported on a scale of 1-4 Minimal depression, 5-9 Mild depression, 10-14 Moderate depression, 15-19 Moderately severe depression, 20-27 Severe depression
Interventions
- BEHAVIORAL Stress Management and Resiliency Training for Depression (SMART-D) Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2023-05-25 |
| Phase | NA |
What the finished NCT04388748 record still lists
NCT04388748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Stress Management and Resiliency Training for Depression (SMART-D) Therapy is the first listed.
NCT04388748 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04388748 about?
NCT04388748 is a clinical study titled "Stress Management and Resiliency Training for Depression vs Treatment as Usual in the Treatment of Major Depression". Researchers are trying to find out if a Stress Management and Resiliency Training (SMART-D) therapy will help with major depression treatment.
What is the current status of trial NCT04388748?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2020-12-18. Estimated completion is 2023-05-25.
What interventions are being tested in trial NCT04388748?
The interventions under investigation include: Stress Management and Resiliency Training for Depression (SMART-D) Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04388748?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04388748's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI